GeneReach Biotechnology Corp. (TPEX:4171)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
19.30
-0.40 (-2.03%)
Apr 29, 2026, 1:30 PM CST
-4.46%
Market Cap 1.11B
Revenue (ttm) 232.74M
Net Income (ttm) -110.28M
Shares Out 57.30M
EPS (ttm) -1.93
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 139,189
Average Volume 210,477
Open 19.70
Previous Close 19.70
Day's Range 19.30 - 20.05
52-Week Range 16.95 - 27.95
Beta 0.52
RSI 48.90
Earnings Date Mar 27, 2026

About GeneReach Biotechnology

GeneReach Biotechnology Corp. develops, manufactures, and markets products for applied nucleic acid detection technology in Taiwan. The company offers various equipment, such as POCKIT Central Nucleic Acid Analyzer, POCKIT Micro Series, taco mini Automatic Nucleic Acid Extraction System, taco Prep Homogenization System, and cubee Mini-Centrifuge; reagents and consumables, including Human IVD Assays, iiPCR Specific Reagents, research reagents and consumables, as well as taco Nucleic Acid Extraction Reagents, IQ REAL Quantitative System, and IQ20... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4171
Full Company Profile

Financial Performance

In 2025, GeneReach Biotechnology's revenue was 232.74 million, an increase of 12.71% compared to the previous year's 206.49 million. Losses were -110.28 million, -7.12% less than in 2024.

Financial Statements

News

There is no news available yet.